Tci Wealth Advisors, Inc. Pacira Bio Sciences, Inc. Transaction History

Tci Wealth Advisors, Inc.

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 08, 2022	SELL	$51.24 - $58.89 $7,942 - $9,127	-155 Reduced 78.28%	43 $2,000
Q4 2021 Jan 24, 2022	BUY	$47.97 - $62.21 $4,317 - $5,598	90 Added 83.33%	198 $12,000
Q3 2021 Oct 29, 2021	BUY	$54.64 - $61.3 $1,202 - $1,348	22 Added 25.58%	108 $6,000
Q2 2021 Aug 02, 2021	BUY	$59.18 - $69.99 $828 - $979	14 Added 19.44%	86 $5,000
Q1 2021 Apr 29, 2021	BUY	$59.31 - $78.82 $1,719 - $2,285	29 Added 67.44%	72 $5,000
Q2 2020 Jul 20, 2020	BUY	$30.8 - $52.47 $1,324 - $2,256	43 New	43 $2,000
Q1 2020 Apr 14, 2020	SELL	$28.4 - $50.7 $1,221 - $2,180	-43 Closed	0 $0
Q4 2019 Jan 27, 2020	BUY	$36.31 - $46.83 $1,561 - $2,013	43 New	43 $2,000

263

50.4M

429K

391K

Ticker PCRX
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 45,824,200
Market Cap $892M
Description
Pacira BioSciences, Inc. provides non-opioid pain management and regenerative health solutions for healthcare practitioners and their patients in the United States. The company offers EXPAREL, a bupivacaine liposome injectable suspension; ZILRETTA, a triamcinolone acetonide extended-release injectable suspension; and iovera system, a non-opioid ...

Get notified when there are updates to the investment portfolio of Tci Wealth Advisors, Inc., based on Form 13F filings with the SEC.

Stay updated on Tci Wealth Advisors, Inc. with notifications on news.